The global burden of pulmonary disease: where we are and where we are going Source: International Congress 2019 – The future of respiratory diseases: what prevention can do Year: 2019
Under- and over-diagnosis of COPD: a global perspective Source: Breathe, 15 (1) 24; 10.1183/20734735.0346-2018 Year: 2019
Impact and economic burden observed in asthma patients considered as mild: an analysis of the respiratory disease specific programme I Source: Annual Congress 2003 - Burden of asthma Year: 2003
Impact of the global economic crisis on the possible increase TB incidence in Serbia Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: epidemiology II Year: 2012
Severe COPD: assessment of impairment, quality of life and burden on health care resources Source: Annual Congress 2004 - PG4 - Management of end-stage patients with COPD Year: 2004
Sex related differences in aetiology, severity and quality of life in bronchiectasis: data from the EMBARC, EMBARC-India and Australian bronchiectasis registries Source: Virtual Congress 2020 – New investigations of bronchiectasis and non-tuberculous mycobacteria Year: 2020
The global perspective of occupational lung disease Source: Eur Respir Monogr 2020; 89: 1-18 Year: 2020
Global burden of non-cystic fibrosis bronchiectasis: A simple epidemiological analysis Source: Annual Congress 2012 - Epidemiology of various respiratory diseases Year: 2012
The quality of life deficit of COPD: evidence from a national population survey Source: Eur Respir J 2002; 20: Suppl. 38, 516s Year: 2002
Targeted pulmonary rehabilitation and nutritional support in patients with COPD: do phenotypic differences matter? Source: International Congress 2017 – PG18 Targeting the locomotor and respiratory muscles in chronic obstructive pulmonary disease: novel interventional tools and rehabilitation strategies Year: 2017
Functional ageing in fibrotic interstitial lung disease: the impact of frailty on adverse health outcomes Source: Eur Respir J, 55 (1) 1900647; 10.1183/13993003.00647-2019 Year: 2020
Educational level of the patients – does it matter for the outcomes of COPD? Source: Annual Congress 2008 - Social determinants and psychological issues in primary care respiratory diseases Year: 2008
The global burden of CPA Source: International Congress 2018 – Chronic pulmonary aspergillosis: from guidelines to real-life implementation Year: 2018
Economic and quality of life consequences of clinically important deterioration in patients with COPD: results from the TORCH study Source: International Congress 2018 – Clinical trials in COPD: new results Year: 2018
Do causes influence clinical, functional and quality of life aspects on patients with bronchiectasis not associated with cystic fibrosis? Source: International Congress 2019 – Chronic cough, a1-antitrypsin deficiency and other conditions Year: 2019
Minimal clinically significant difference in health status: the thorny path of health status measures? Source: Eur Respir J 2002; 19: 390-391 Year: 2002
External validation of exacerbation and mortality outcomes of health economic decision models for COPD Source: International Congress 2016 – Prevalence, prognosis, and risk factors of COPD Year: 2016